As lung cancer treatments evolve and more data are published, there is a need for updated recommendations on how to manage ...

Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer ...

Dr. Jacob A. Sands shares how patients with lung cancer can interpret clinical trial results and how these findings translate to treatment decisions.

Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...

Former US President Barack Obama recently met a 102-year-old woman and playfully asked her about the secret behind her long life. During the interaction, he specifically inquired about her diet, ...

Since the development of crizotinib (Xalkori), oncologists can now choose from an array of later-generation drugs in the ...

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

Dr. Anshul clarifies that while early breast cancer improves survival rates, recurrence risk remains high, especially in ...

When you're facing metastatic breast cancer, the questions can pile up fast. Here are some clear answers to guide you.

Galleri’s multi-cancer blood test promises early cancer detection but faces doubts over accuracy, safety, and real survival ...

Kelly Paulson, MD, PhD: ES-SCLC is, of course, a very aggressive form of lung cancer that affects about 35,000 Americans each. Most SCLC presents in the metastatic setting or extensive stage, and ...